GE Healthcare Life Sciences said today that it has entered into a strategic R&D and distribution partnership with Advanced Solutions Life Sciences — with a goal of personalized tissue regeneration. The partnership with Advanced Solutions Life Sciences is the latest in a string of investments and partnerships that GE Healthcare (NYSE:GE) has been making to further a wide array of medtech innovation — from 3D printing to robot-assisted surgery to artificial intelligence to digital health.
Update: GE Healthcare Life Sciences is now Cytiva.